ZS Pharma, Inc.

About ZS Pharma, Inc.

From manufacturing to technology to people, ZS Pharma is thinking differently about developing therapies to address unmet needs.

ZS Pharma was founded in 2008, became a public company in 2014 and, in December 2015, joined the AstraZeneca Group. We are a biopharmaceutical company dedicated to challenging the status quo in disease areas where therapeutic options have been limited. We are currently focused on using our proprietary ion-trap technology to develop new treatments.

The ZS Pharma team combines deep knowledge and experience with an unparalleled drive to provide innovative new medicines for patients, families and physicians facing serious, difficult-to-treat diseases.

We are developing new options in treating ion imbalances, and are currently executing a robust clinical development program for our first product candidate: ZS-9 for the treatment of hyperkalemia. Hyperkalemia, or high serum potassium, results in serious clinical complications in both acute and chronic settings. Even mild hyperkalemia is associated with an increased risk of adverse renal events and increased mortality in patients with chronic illnesses. Causes of hyperkalemia include chronic diseases and lifesaving therapies, such as renin-angiotensin-aldosterone system inhibition (RAASi) therapy. Hyperkalemia occurs frequently in patients with other serious comorbidities, increasing their risk of complications.

We are working toward launching ZS-9 in the U.S. ZS-9 uses new technology that is hypothesized to mimic natural ion channels to make it difficult for ions other than potassium and ammonium to enter its crystalline structure. ZS9 is an insoluble, non-absorbed zirconium silicate designed to preferentially trap potassium ions in order to lower and maintain serum potassium levels.

Website	http://www.zspharma.com
Employees	11-50 employees View all ZS Pharma, Inc. employees
Industry	Biotechnology
Headquarter	1100 Park Place Suite 300, San Mateo, California 94403, US
Founded	2008
Keywords	Biotechnology, Regulatory, Pharmaceutical, Sales, Drug

Get verified email of ZS Pharma, Inc. employees

ZS Pharma, Inc. Alternatives

Sapphire Energy Inc.

biotechnology

Dem Medic Pharma Limited

Biotechnology

Allahdin Group of Companies

Biotechnology

Macrogen Inc.

biotechnology

N R C

Biotechnology

Expedeon Inc. (an Abcam company)

biotechnology

Integral Molecular

biotechnology

Chr. Hansen

biotechnology

Frequently Asked Questions about ZS Pharma, Inc.

Who are the decision makers in ZS Pharma, Inc.?

The decision makers in ZS Pharma, Inc. are Alejandro Leon, Brent Yoches, Daniel Wagner, etc. Click to Find ZS Pharma, Inc. decision makers emails.

What types of therapies does ZS Pharma develop?

ZS Pharma focuses on developing innovative therapies primarily in the biotechnology and pharmaceutical sectors. The company specializes in addressing unmet medical needs, particularly in areas such as renal health and cardiovascular diseases. Their approach combines advanced manufacturing techniques with cutting-edge technology to create effective treatment options.

How does ZS Pharma ensure regulatory compliance in its drug development process?

ZS Pharma has a dedicated regulatory affairs team that works closely with health authorities to ensure compliance with all applicable regulations and guidelines. The team is involved throughout the drug development process, from preclinical studies to clinical trials and post-marketing surveillance, ensuring that all products meet the necessary safety and efficacy standards.

What industries does ZS Pharma support with its solutions?

ZS Pharma primarily supports the biotechnology and pharmaceutical industries. Their solutions are tailored to meet the needs of these sectors, focusing on drug development, regulatory compliance, and innovative manufacturing processes. The company collaborates with various stakeholders, including healthcare providers and research institutions, to advance therapeutic options.

Can ZS Pharma assist with the commercialization of new drugs?

Yes, ZS Pharma offers comprehensive support for the commercialization of new drugs. This includes market analysis, strategic planning, and sales support to ensure that new therapies reach the intended patient populations effectively. Their experienced sales team works to build relationships with healthcare professionals and stakeholders to facilitate successful product launches.

What is the significance of ZS Pharma's focus on unmet medical needs?

ZS Pharma's focus on unmet medical needs is crucial as it drives innovation and the development of therapies that address gaps in current treatment options. By identifying and targeting these areas, ZS Pharma aims to improve patient outcomes and enhance the quality of life for individuals suffering from conditions that lack effective treatments.

How can I stay updated on ZS Pharma's latest developments and offerings?

To stay updated on ZS Pharma's latest developments, you can visit their official website and subscribe to their newsletter. Additionally, following them on social media platforms and checking industry news outlets can provide timely information on new therapies, research findings, and company announcements.